Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Cancer Research
Ganglioside Containing Nano-Proteoliposome Dampens Myeloid-Derived Suppressor Cells Function and Ability to Cross-Present Tumor Antigens: A New Approach to Recover CTL Function on Tumor Bearing Individuals
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Nano-Pulse Stimulation Is a Physical Modality That Can Trigger Immunogenic Tumor Cell Death
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
In Vitro Generation of Allo-Reactive Human NK Cells From Umblillical Cord Blood CD34+ Progenitor Cells
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
S80. Prolongation of T Cell Response by OX40 Co-Signalling CARS
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Late-Differentiated Effector Neoantigen-Specific CD8+ T Cells Are Enriched in Peripheral Blood of Non-Small Cell Lung Carcinoma Patients Responding to Atezolizumab Treatment
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Angiosarcoma Patients Treated With Immune Checkpoint Inhibitors: A Case Series of Seven Patients From a Single Institution
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The Motility Regulator flhDC Drives Intracellular Accumulation and Tumor Colonization of Salmonella
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Cancer Immunotherapy With Multiple Tumor Antigen Activated Autologous T Cells in Patients With HBV Related Hepatocellular Carcinoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Phase III Study (CheckMate 238) of Adjuvant Immunotherapy With Nivolumab (NIVO) Versus Ipilimumab (IPI) After Complete Resection of Stage IIIb/c or Stage IV Melanoma (MEL) in Patients (Pts) at High Risk for Recurrence
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Infiltration of Immune Cells Into Cancer Cell/Stroma Cell 3D Microtissues
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
‹
251
252
253
254
255
256
257
›
